Market Research Future

Global Thyroid Disorder Market Which Was US$1990 Million in 2016 to Reach US$2400.8 Million by 2022, Growing with a CAGR of 3.1%

Global Thyroid Disorder Market Information, by Treatment (drugs and supplements, diagnostics and surgery), by Disease Indication (hypothyroidism, hyperthyroidism and other), by Route of Administration (oral, injectable and others) and by End Users (hospitals and home use) - Forecast till 2022


Pune, India -- (SBWIRE) -- 05/22/2017 -- Market Scenario:
Thyroid gland convert iodine taken from food into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism, growth and development, intelligence deficit etc. Thyroid hormones also affect fertility, kidney functions and cardiac functions as well. According to the international thyroid society almost 20 million Americans suffer from some form of thyroid disease and more than 12 percent of the U.S. population will develop a thyroid condition during their lifetime. The World Health Organization (WHO) has identified that iodine deficiency can easily be prevented which if not done can cause brain damage.

Request for sample report at .

The market driving factors for world thyroid disorder market are growing screening and prevalence of thyroid disorders, good reimbursement for treatment and increasing awareness of implications of thyroid disorders.
Other factors driving the market's growth are rise in risk factors such as obesity, diabetes, auto immune diseases etc. For example the percentage of the population diagnosed with hashimoto's thyroiditis is growing and its occurrence is twice in patients who have diabetes. Increasing focus of developing regions' governments on the healthcare sector is also driving the thyroid disorders treatment market. Rise in the number of thyroid cancer cases and the high cure rates of thyroid cancer is another factor driving the growth of this market.
The market's restraints are the costs associated with the treatment and the rise of alternative medicines for the treatment of thyroid disorders. However, side-effects associated with the current medication is the most critical restraint. Thyroid disorders treatment medication have a low therapeutic index which is the difference between safe and effective dose.
The market for thyroid disorders is a consolidated market with few companies dominating the market. Among the hypothyroidism drugs Levothyroxine, Cytomel and Liothyronine top the market, while hyperthyroidism market leaders include imidazole and propacil.
Taking all the factors into consideration, we expect the global thyroid disorder market which was US$1990 million in 2016 to reach US$2400.8 million by 2022, growing with a CAGR of 3.1%.

Browse complete report at .

Study Objectives Global Thyroid Disorder Market:
- To provide detail analysis of the market structure along with forecast for the next 6 years of various segments and sub-segments of the global thyroid disorder market
- To provide insights about factors affecting the market growth
- To analyze the market based on various analyses which includes price analysis, supply chain analysis, Porters Five Force analysis etc.
- To provide past and estimated future revenue of the market's segments and sub-segments with respect to four main geographies and their countries which includes Americas, Europe, Asia-Pacific, and Middle East & Africa.
- To provide country level analysis of the market with respect to the current market size and future growth prospect.
- To provide country level analysis of the market for segments which includes by treatment (drugs and supplements, diagnostics and surgery), by disease indication (hypothyroidism, hyperthyroidism and other), by route of administration (oral, injectable and others) and by end users (hospitals and home use)
- To provide overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape for the market
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments globally.

Key Players for Global Thyroid Disorder Market:
- Allergan
- Abbott Laboratories
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Pfizer Inc.
- AbbVie
- Mylan

Request for Discount

Intended Audience
- Thyroid diagnostic and surgical manufacturers
- Anti-thyroid disorder drugs suppliers
- Private research laboratories
- Research and development (R&D) companies
- Market research and consulting service providers
- Government research laboratories
- Contract manufacturing organizations

Regional Analysis of Global Thyroid Disorder Market:
Globally America is the largest market for thyroid disorder and Europe is the second-largest market. Developed regions are expected to lose their market leadership in future due to growing Asia Pacific region which is expected to be the fastest growing region in thyroid disorder market. This region will be led by China and India. Africa is expected to be a moderately growing market in the global thyroid disorder market.
The report for global thyroid disorder market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the global thyroid market's segments and regions.

Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter's Five Forces Model

4.1.1 Bargaining Power of Suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor's

4.1.4 Threat of New Entrants

5 Global Thyroid Disorders Market, by Treatment

5.1 Introduction

5.2 Drugs And Supplements

5.3 Diagnostics

5.4 Surgery

6 Global Thyroid Disorders Market, By Disease Indication

6.1 Introduction

6.2 Hypothyroidism

6.3 Hyperthyroidism

6.4 Others

7 Global Thyroid Disorders Market, By Route of Administration

7.1 Introduction

7.2 Oral

7.3 Injectable

7.4 Others

8 Global Thyroid Disorders Market, By End Users

8.1 Introduction

8.2 Hospitals

8.3 Home Use

8 Global Thyroid Disorders market, by Regions

8.1 Introduction

8.1.1 Americas North America South America

8.1.2 Europe Germany France UK Italy Spain Rest of Europe

8.1.3 Asia Pacific Japan China India Republic of Korea Rest of Asia Pacific

8.1.4 Middle East & Africa

9 Company Landscape

9.1 Introduction

9.1.1 Mergers Acquisitions

9.1.2 Collaborations

9.1.3 Release/New Product Launches

9.1.4 Other (Expansion, Updates, Partnership)

10 Company Profile

10.1 Allergan

10.1.1 Company Overview

10.1.2 Product/Business Segment Overview

10.1.3 Financials

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Abbott Laboratories

10.2.1 Overview

10.2.2 Product/Business Segment Overview

10.2.3 Financials

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 GlaxoSmithKline plc

10.3.1 Overview

10.3.2 Product/Business Segment Overview

10.3.3 Financials

10.3.4 Key Developments

10.3.5 SWOT Analysis

10.4 Merck & Co., Inc.

10.4.1 Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financials

10.4.4 Key Developments

10.4.5 SWOT Analysis

10.5 Pfizer Inc.

10.5.1 Overview

10.5.2 Product/Business Segment Overview

10.5.3 Financials

10.5.4 Key Developments

10.5.5 SWOT Analysis


10.6.1 Overview

10.6.2 Product/Business Segment Overview

10.6.3 Financials

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 AbbVie

10.7.1 Overview

10.7.2 Product/Business Segment Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.7 Mylan

10.7.1 Overview

10.7.2 Product/Business Segment Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

11 Others

12 Appendix

Akash Anand
Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: Akash.Anand@Marketresearchfuture.Com
Web: Https://Www.Marketresearchfuture.Com